Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 04, 2020

SELL
$47.45 - $62.95 $255,281 - $338,671
-5,380 Closed
0 $0
Q2 2020

Aug 03, 2020

BUY
$46.85 - $61.05 $252,053 - $328,449
5,380 New
5,380 $317,000

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $5.69B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Dc Investments Management, LLC Portfolio

Follow Dc Investments Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dc Investments Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dc Investments Management, LLC with notifications on news.